MedPath

ECLYPIA

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

SKAMo-1: Characterization of the Upper Layers of Skin

Not Applicable
Completed
Conditions
Diabetes
Interventions
Other: Experimental
First Posted Date
2023-09-21
Last Posted Date
2023-09-21
Lead Sponsor
Eclypia
Target Recruit Count
14
Registration Number
NCT06044532
Locations
🇫🇷

CHU Grenoble Alpes, Grenoble, France

SKAMo-2: the Real-life Test of Continuous Photoacoustic Signal by Neogly in Patients With Type I Diabetes

Not Applicable
Recruiting
Conditions
Diabetes
Interventions
Device: Non-invasive continuous monitoring device to record photoacoustic signal
First Posted Date
2023-09-13
Last Posted Date
2023-09-13
Lead Sponsor
Eclypia
Target Recruit Count
10
Registration Number
NCT06035367
Locations
🇫🇷

CHU Grenoble Alpes, Grenoble, France

© Copyright 2025. All Rights Reserved by MedPath